Five-Year Results of a Randomized Controlled Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease

BACKGROUND CONTEXT: The activL artificial disc received Food and Drug Administration approval in 2015 based on 2-year follow-up data. Long-term outcomes with this lumbar total disc replacement have not been reported to date.

Source: The Spine Journal - October 1, 2017 Category: Orthopaedics Authors: James J. Yue, Rolando Garcia Source Type: research